Antimalarial drug discovery: old and new approaches
- 1 November 2003
- journal article
- review article
- Published by The Company of Biologists in Journal of Experimental Biology
- Vol. 206 (21) , 3735-3744
- https://doi.org/10.1242/jeb.00589
Abstract
SUMMARY: New drugs against malaria are greatly needed. Many approaches to antimalarial drug discovery are available. These approaches must take into account specific concerns, in particular the requirement for very inexpensive and simple to use new therapies and the need to limit the cost of drug discovery. Among important efforts that are currently ongoing are the optimization of therapy with available drugs, including the use of combination therapy, the development of analogs of existing agents, the discovery of natural products, the use of compounds that were originally developed against other diseases, the evaluation of drug resistance reversers, and the consideration of new chemotherapeutic targets. The last category benefits from recent advances in malaria research technologies and genomics and is most likely to identify new classes of drugs. A number of new antimalarial therapies will likely be needed over the coming years, so it is important to pursue multiple strategies for drug discovery.Keywords
This publication has 96 references indexed in Scilit:
- Reemergence of Chloroquine‐SensitivePlasmodium falciparumMalaria after Cessation of Chloroquine Use in MalawiThe Journal of Infectious Diseases, 2003
- Synthesis and Effects on Chloroquine Susceptibility in Plasmodium falciparum of a Series of New Dihydroanthracene DerivativesJournal of Medicinal Chemistry, 2002
- Medical need, scientific opportunity and the drive for antimalarial drugsNature, 2002
- Comparison of Efficacies of Cysteine Protease Inhibitors against Five Strains of Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2001
- Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind studyThe Lancet, 2000
- Randomized Dose‐Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse ofPlasmodium vivaxMalaria in ThailandThe Journal of Infectious Diseases, 1999
- Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial DrugsScience, 1999
- The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial designNature Structural & Molecular Biology, 1996
- Reversal of Chloroquine Resistance in Malaria Parasite Plasmodium falciparum by DesipramineScience, 1988
- Reversal of Chloroquine Resistance in Plasmodium falciparum by VerapamilScience, 1987